Huiping W. Wang

Hefei, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 81 publications

Corrigendum to "Electronic key-lock matching underpins exclusive recognition of hydrogen sulfide by fluorescent-nanozyme carbon dots" [Biosens. Bioelectron. 309 (2026) 118782].

Corrigendum to "Electronic key-lock matching underpins exclusive recognition of hydrogen sulfide by fluorescent-nanozyme carbon dots" [Biosens. Bioelectron. 309 (2026) 118782].

Journal: Biosensors & bioelectronics
Published: June 01, 2026

Peritoneal effusion as a marker of disease severity in secondary hemophagocytic lymphohistiocytosis: Clinical and immunological insights.

Peritoneal effusion as a marker of disease severity in secondary hemophagocytic lymphohistiocytosis: Clinical and immunological insights.

Journal: SAGE open medicine
Published: May 31, 2026

Targeting CD74 may mitigate immune-escape features and enhance BCMA CAR-T activity in preclinical models of relapsed/refractory multiple myeloma.

Targeting CD74 may mitigate immune-escape features and enhance BCMA CAR-T activity in preclinical models of relapsed/refractory multiple myeloma.

Journal: Journal for immunotherapy of cancer
Published: April 28, 2026

Stage-resolved cytokine profiling nominates IL-17 as a prognostic node in relapsed/refractory B-cell lymphoma.

Stage-resolved cytokine profiling nominates IL-17 as a prognostic node in relapsed/refractory B-cell lymphoma.

Journal: Cytokine
Published: April 02, 2026

Multi-omics integration of molecular genetics, cytogenetics and immunophenotyping: a novel prognostic model for immune landscape characterization and outcome prediction in Chinese patients with acute myeloid leukemia.

Multi-omics integration of molecular genetics, cytogenetics and immunophenotyping: a novel prognostic model for immune landscape characterization and outcome prediction in Chinese patients with acute myeloid leukemia.

Journal: Frontiers in immunology
Published: February 17, 2026

An early integrated prognostic system for predicting relapse and guiding intervention post-CD19 CAR-T therapy in B-cell acute lymphoblastic leukaemia.

An early integrated prognostic system for predicting relapse and guiding intervention post-CD19 CAR-T therapy in B-cell acute lymphoblastic leukaemia.

Journal: British journal of haematology
Published: January 18, 2026

Electronic key-lock matching underpins exclusive recognition of hydrogen sulfide by fluorescent-nanozyme carbon dots.

Electronic key-lock matching underpins exclusive recognition of hydrogen sulfide by fluorescent-nanozyme carbon dots.

Journal: Biosensors & bioelectronics
Published: December 19, 2025

Aptamer-engineered NIR-II Ru-doped carbon quantum dot nanozyme for photoacoustic imaging-guided synergistic photothermal and catalytic cancer therapy.

Aptamer-engineered NIR-II Ru-doped carbon quantum dot nanozyme for photoacoustic imaging-guided synergistic photothermal and catalytic cancer therapy.

Journal: Journal of nanobiotechnology
Published: October 14, 2025

Case Report: A rare case of synchronous ovarian mixed germ cell tumor and mast cell leukemia in a pediatric patient.

Case Report: A rare case of synchronous ovarian mixed germ cell tumor and mast cell leukemia in a pediatric patient.

Journal: Frontiers in oncology
Published: October 01, 2025

Corrigendum to "Phenylenediamine-derived carbon dots coupled with rhodamine B: Ultrafast ratiometric fluorescence and smartphone-enabled imaging detection of nitrite" [Food Chem. 493(Part 2) (2025) 145774].

Corrigendum to "Phenylenediamine-derived carbon dots coupled with rhodamine B: Ultrafast ratiometric fluorescence and smartphone-enabled imaging detection of nitrite" [Food Chem. 493(Part 2) (2025) 145774].

Journal: Food chemistry
Published: September 10, 2025

Targeting CCR7-KMT2D enhances CAR-T cell efficacy by suppressing therapy-induced senescence in B-cell non-Hodgkin lymphoma.

Targeting CCR7-KMT2D enhances CAR-T cell efficacy by suppressing therapy-induced senescence in B-cell non-Hodgkin lymphoma.

Journal: BMC medicine
Published: July 27, 2025

CBX7 regulates chemotherapy-induced senescence-like growth arrest in multiple myeloma via the ERK/STAT3/PIM1 axis.

CBX7 regulates chemotherapy-induced senescence-like growth arrest in multiple myeloma via the ERK/STAT3/PIM1 axis.

Journal: Journal of translational medicine
Published: July 03, 2025
Showing 1-12 of 81

Last Updated: 09/26/2026